Drug Shortage Report for IRBESARTAN
Report ID | 82512 |
Drug Identification Number | 02372347 |
Brand name | IRBESARTAN |
Common or Proper name | IRBESARTAN |
Company Name | SANIS HEALTH INC |
Market Status | MARKETED |
Active Ingredient(s) | IRBESARTAN |
Strength(s) | 75MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-05-10 |
Actual start date | 2019-05-10 |
Estimated end date | 2019-05-31 |
Actual end date | 2019-06-03 |
Shortage status | Resolved |
Updated date | 2019-06-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2019-06-04 | English | Compare |
v7 | 2019-06-03 | French | Compare |
v6 | 2019-06-03 | English | Compare |
v5 | 2019-05-11 | English | Compare |
v4 | 2019-05-10 | French | Compare |
v3 | 2019-05-10 | English | Compare |
v2 | 2019-04-26 | French | Compare |
v1 | 2019-04-26 | English | Compare |
Showing 1 to 8 of 8